Showing results (51-60 of 64) with videos related to
Sort By:
Pageof 7
Chest|September 29, 2021
Acute Management of High-Risk and Intermediate-Risk Pulmonary Embolism in Children: A ReviewCatherine Ross, Riten Kumar, Marie-Claude Pelland-Marcotte, et al.Blood|July 15, 2022
Moderate-intensity aerobic exercise vs desmopressin in adolescent males with mild hemophilia A: a randomized trialRiten Kumar, Amy L Dunn, Jane E Schneiderman, et al.Blood|April 25, 2021
Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-CHilary Whitworth, Sarah E Sartain, Riten Kumar, et al.The Lancet. Haematology|August 18, 2019
Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studiesPaul Monagle, Anthonie W A Lensing, Kirstin Thelen, et al.American Journal of Clinical Oncology|April 9, 2013
Rare presentations of primary melanoma and special populations: a systematic reviewLisa A Kottschade, Travis E Grotz, Roxana S Dronca, et al.Journal of Thrombosis and Haemostasis : JTH|April 5, 2020
Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr phase 3 dose-exposure-response evaluationGuy Young, Anthonie W A Lensing, Paul Monagle, et al.Blood Advances|May 27, 2025
American Society of Hematology/International Society on Thrombosis and Haemostasis 2024 updated guidelines for treatment of venous thromboembolism in pediatric patientsPaul Monagle, Muayad Azzam, Rachel Bercovitz, et al.Blood Advances|December 22, 2020
Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT)Philip Connor, Mayte Sánchez van Kammen, Anthonie W A Lensing, et al.Blood Advances|April 8, 2026
ASH ISTH 2026 guidelines for Anticoagulant Prophylaxis of Pediatric Patients at Risk of Venous ThromboembolismMarisol Betensky, Muayad Azzam, Rachel Sara Bercovitz, et al.The Lancet. Haematology|November 9, 2019
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trialChristoph Male, Anthonie W A Lensing, Joseph S Palumbo, et al.Pageof 7